You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Details for Patent: 9,867,792


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,867,792 protect, and when does it expire?

Patent 9,867,792 protects GOCOVRI and is included in one NDA.

This patent has nineteen patent family members in eight countries.

Summary for Patent: 9,867,792
Title:Method of administering amantadine prior to a sleep period
Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
Inventor(s): Went; Gregory T. (Mill Valley, CA), Sathyan; Gayatri (Bangalore, IN), Vermani; Kavita (Fremont, CA), Ganapati; Gangadhara (Palo Alto, CA), Coffee; Michael (Tiburon, CA), Shek; Efraim (Pleasanton, CA), Katdare; Ashok (Berkeley, CA)
Assignee: Adamas Pharma, LLC (Emeryville, CA)
Application Number:15/428,980
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,867,792
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,867,792: A Comprehensive Guide

Introduction

When analyzing a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will provide a detailed analysis of the scope and claims of United States Patent 9,867,792, using various tools and resources available from the U.S. Patent and Trademark Office (USPTO) and other relevant sources.

Understanding Patent Scope and Claims

What are Patent Claims?

Patent claims define the scope of protection granted by a patent. They are the legal boundaries that distinguish the invention from prior art and other existing technologies[3].

Importance of Claim Construction

Claim construction is a critical step in patent litigation, as it determines the meaning and scope of the claims. It is a question of law reviewed de novo on appeal, and any underlying factual findings are reviewed for clear error[5].

Tools for Patent Analysis

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for analyzing patents. It replaces legacy search tools like PubEast and PubWest, offering enhanced access to prior art through two modern interfaces. This tool allows users to search and analyze patent documents, including claims, descriptions, and drawings[1].

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices, including the IP5 Offices. This service is useful for seeing the patent family for a specific application, along with classification, citation data, and office actions[1].

Cooperative Patent Classification (CPC)

The CPC database is essential for finding relevant classification schemes. It allows users to search and classify patents based on a harmonized classification system used by the USPTO and the European Patent Office[4].

Analyzing United States Patent 9,867,792

Patent Details

To analyze the scope and claims of United States Patent 9,867,792, start by retrieving the patent document using the Patent Public Search tool or other patent databases.

Claim Analysis

  • Independent Claims: These claims stand alone and do not depend on other claims. They define the broadest scope of the invention.
  • Dependent Claims: These claims depend on one or more independent claims and narrow down the scope of the invention.
  • Claim Construction: Analyze each claim to understand its meaning and scope. This involves identifying key terms, understanding the context, and considering any limitations or dependencies[5].

Prior Art and Citation Analysis

Use the Common Citation Document (CCD) application to consolidate citation data from participating IP Offices. This helps in identifying prior art cited by multiple offices, which can impact the validity and scope of the patent claims[1].

Patent Family and Global Dossier

Examine the patent family for United States Patent 9,867,792 using the Global Dossier service. This will provide insights into related applications filed at other IP Offices, including their status, classification, and citation data[1].

Statistical Analysis Using Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset can be used to analyze claims data statistically. This dataset contains detailed information on claims from US patents granted between 1976 and 2014 and US patent applications published between 2001 and 2014. It includes claim-level statistics and document-level statistics, which can help in understanding the scope and breadth of the patent claims[3].

Practical Steps for Analysis

Step 1: Retrieve the Patent Document

Use the Patent Public Search tool or other patent databases to retrieve the full text of United States Patent 9,867,792.

Step 2: Identify and Analyze Claims

Carefully read and analyze each claim, distinguishing between independent and dependent claims. Use resources like the Cooperative Patent Classification (CPC) database to understand the classification and scope of the claims[4].

Step 3: Conduct Prior Art Search

Perform a thorough prior art search using tools like the Patent Public Search and the Common Citation Document (CCD) application to identify any relevant prior art that may impact the patent's validity[1].

Step 4: Review Patent Family and Global Dossier

Access the Global Dossier service to review the patent family and related applications filed at other IP Offices. This will help in understanding the broader patent landscape and any potential challenges or opportunities[1].

Step 5: Analyze Office Actions and Citations

Review office actions and citations using the Global Dossier and CCD applications. This will provide insights into any challenges faced during the patent prosecution process and how they were addressed[1].

Case Law and Legal Considerations

Claim Indefiniteness

Ensure that the claims are not indefinite, as this is a legal conclusion that can invalidate a patent. Claim indefiniteness is reviewed de novo, with underlying factual findings reviewed for clear error[5].

Claim Construction on a Claim-by-Claim Basis

Conduct claim construction on a claim-by-claim basis, ensuring that each claim is consistent with the disclosed subject matter and does not force mutually exclusive interpretations[5].

Conclusion

Analyzing the scope and claims of a patent like United States Patent 9,867,792 involves a meticulous process that includes using various tools and resources provided by the USPTO and other patent offices. By understanding the claims, prior art, and global patent landscape, one can gain a comprehensive view of the patent's validity, enforceability, and market impact.

Key Takeaways

  • Use Advanced Search Tools: Utilize the Patent Public Search, Global Dossier, and Common Citation Document (CCD) applications for thorough analysis.
  • Analyze Claims Carefully: Distinguish between independent and dependent claims and ensure they are not indefinite.
  • Conduct Prior Art Search: Identify relevant prior art to assess the patent's validity.
  • Review Patent Family: Use the Global Dossier to understand related applications and their status.
  • Consider Legal Aspects: Ensure claim construction is done on a claim-by-claim basis and that claims are not mutually exclusive.

FAQs

Q: What is the importance of claim construction in patent analysis?

A: Claim construction is crucial as it determines the meaning and scope of the claims, which is a question of law reviewed de novo on appeal.

Q: How can I access prior art related to a specific patent?

A: Use the Common Citation Document (CCD) application to consolidate citation data from participating IP Offices.

Q: What is the Global Dossier service, and how is it useful?

A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, helping users understand the broader patent family and landscape.

Q: How can I ensure that patent claims are not indefinite?

A: Ensure that each claim informs those skilled in the art with reasonable certainty, and avoid mutually exclusive interpretations.

Q: What resources are available for training in patent search techniques?

A: The USPTO's Patent and Trademark Resource Centers (PTRCs) offer training in patent search techniques, including computer-based training tutorials[1][4].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,867,792

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Supernus Pharms GOCOVRI amantadine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 208944-001 Aug 24, 2017 AB RX Yes No ⤷  Subscribe ⤷  Subscribe TREATMENT OF DYSKINESIA IN PATIENTS WITH PARKINSON'S DISEASE RECEIVING LEVODOPA-BASED THERAPY, WITH OR WITHOUT CONCOMITANT DOPAMINERGIC MEDICATIONS ⤷  Subscribe
Supernus Pharms GOCOVRI amantadine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 208944-002 Aug 24, 2017 RX Yes Yes ⤷  Subscribe ⤷  Subscribe TREATMENT OF DYSKINESIA IN PATIENTS WITH PARKINSON'S DISEASE RECEIVING LEVODOPA-BASED THERAPY, WITH OR WITHOUT CONCOMITANT DOPAMINERGIC MEDICATIONS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,867,792

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2010325960 ⤷  Subscribe
Australia 2015202356 ⤷  Subscribe
Brazil 112012013487 ⤷  Subscribe
Canada 2782556 ⤷  Subscribe
Canada 2994873 ⤷  Subscribe
China 102883601 ⤷  Subscribe
China 106389381 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.